Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Endocrine advantages of PD-1/PD-L1 therapy: Comparative analysis of FAERS-JADER

  • Yuxuan Gao,
  • Shiyao Jiang,
  • Yu Cui,
  • Yumeng Wang,
  • Lili Yu

The Funding statement for this article is incomplete. The correct Funding statement is as follows: This work was supported by the Shandong Second Medical University(China), Postgraduate Research Innovation Fund Project [Project Number: 2023YJSCX023], Recipient: Yuxuan Gao; the Shandong Province Medical and Health Technology Project(China) [Project Number: 202412051156], Recipient: Lili Yu; and the Science and Technology Development Project for the Affiliated Hospital of Shandong Second Medical University(China) [Project Number: 2023FYZ015], Recipient: Lili Yu.

Reference

  1. 1. Gao Y, Jiang S, Cui Y, Wang Y, Yu L. Endocrine advantages of PD-1/PD-L1 therapy: Comparative analysis of FAERS-JADER. PLoS One. 2026;21(1):e0340794. pmid:41511993

Citation: Gao Y, Jiang S, Cui Y, Wang Y, Yu L (2026) Correction: Endocrine advantages of PD-1/PD-L1 therapy: Comparative analysis of FAERS-JADER. PLoS One 21(3): e0344694. https://doi.org/10.1371/journal.pone.0344694

Published: March 10, 2026

Copyright: © 2026 Gao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.